Product Information

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG is a generic product labeled by Endo USA Inc., priced at $1.0719 per EA under NDC 49884079009. Its NADAC has been published 506 times since Mar 15, 2017.

FDA first approved this application on Oct 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
$1.0719per EA

Strength

10; 25; 40 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884079009

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206137

FDA Approved

10/26/2016

TE Code

AB

On Market Since

10/26/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has been published 506 times since Mar 15, 2017, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0719 per EA
All-time high$3.4731 (May 10, 2017)
All-time low$0.9895 (Sep 23, 2026)
52-week high$1.3916
52-week low$0.9895
Median price$1.7218
Average price$1.8456
Largest weekly change+29.2% (Dec 23, 2020)
Weeks tracked506
Tracking sinceMar 15, 2017

Price History

1W

+6.4%

1M

+8.3%

3M

+3.7%

6M

-7.6%

1Y

-23.0%

3Y

-25.9%

5Y

-40.5%

All

-67.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG, manufactured by Endo USA Inc., is $1.0719 per EA (NDC 49884079009), effective Nov 18, 2026.

How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG changed over time?

Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has declined 67.2%. It has been tracked across 506 weekly CMS publications since Mar 15, 2017.

What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

Since Mar 15, 2017, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has ranged from a low of $0.9895 (Sep 23, 2026) to a high of $3.4731 (May 10, 2017), with a median of $1.7218 per EA.

Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG (NDC 49884079009) is labeled by Endo USA Inc., and CMS classifies it as a generic product.